Frontiers | A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects
POS0950 LONG-TERM FOLLOW-UP OF STARTING AND SWITCHING FROM ORIGINAL ADALIMUMAB TO ADALIMUMAB BIOSIMILAR: REAL-WORLD DATA IN AXIAL SPONDYLOARTHRITIS | Annals of the Rheumatic Diseases
Anti-Adalimumab ELISA Kit (Humira®) Free Drug/ADA
Shikari® (Q-ADA) Adalimumab ELISA - Matriks Biotek
Frontiers | A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis | Clinical Pharmacokinetics
Pharmaceutics | Free Full-Text | Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting
Kaplan-Meier curves of time to ADA discontinuation in patients in the... | Download Scientific Diagram
Anti‐TNF treatment negatively regulates human CD4+ T‐cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype - Povoleri - 2020 - European Journal of Immunology - Wiley Online Library
HUMIRA® (adalimumab) for Pediatric Ulcerative Colitis (UC)
Co-formulations of adalimumab with hyaluronic acid/polyvinylpyrrolidone to combine intraarticular drug delivery and viscosupplementation - ScienceDirect
Adalimumab Antibody ELISA Kit (ABIN2862660)
Healthcare Pharmaceuticals
Adalimumab (ADA) treatment enhances IL‐10 production in multiple... | Download Scientific Diagram
Anti-Adalimumab ELISA Assay Kit | Humira ELISA | Eagle Bio
Adalimumab (ADA) - Dr. von Kiedrowski, Selters
Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry | The Journal of Rheumatology
Rates of adalimumab (ADA) discontinuation according to the quartiles of... | Download Scientific Diagram
Anti-Adalimumab Antibodies (Humira) | Bio-Rad
Assessment of immunogenicity and drug activity in patient sera by flow-induced dispersion analysis | Scientific Reports
